Revatio Special Investigation for Long-term Use in Pediatric Patients

CompletedOBSERVATIONAL
Enrollment

1,023

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

August 30, 2022

Study Completion Date

August 30, 2022

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Sildenafil

"\[REVATIO® Tablets / REVATIO® OD Film\] Adults Usually, sildenafil 20 mg is orally given three times daily. Children aged 1 year or older In children weighing 20 kg or more: Usually, sildenafil 20 mg is orally given three times daily.~\[REVATIO® Dry Syrup for Suspension\] Adults Usually, sildenafil 20 mg is orally given three times daily. Children aged 1 year or older In children weighing 8 kg or more but less than 20 kg: Usually, sildenafil 10 mg is orally given three times daily.~In children weighing 20 kg or more: Usually, sildenafil 20 mg is orally given three times daily."

Trial Locations (1)

Unknown

Viatris Pharmaceuticals Japan Inc., 5-11-2; Toranomon, Minato-ku, Tokyo

All Listed Sponsors
lead

Viatris Pharmaceuticals Japan Inc

INDUSTRY

NCT03364244 - Revatio Special Investigation for Long-term Use in Pediatric Patients | Biotech Hunter | Biotech Hunter